Cumberland Pharmaceuticals Inc. (CPIX) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -10.92M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-10.92M | (m) |
| 2026-03-31 | (m) | $-7.38M | (m) |
| 2025-12-31 | (m) | $-2.84M | (m) |
| 2025-09-30 | (m) | $-3.33M | (m) |
| 2025-06-30 | (m) | $-2.93M | (m) |
| 2025-03-31 | (m) | $-3.28M | (m) |
| 2024-12-31 | (m) | $-6.48M | (m) |
| 2024-09-30 | (m) | $-10.87M | (m) |
| 2024-06-30 | (m) | $-10.38M | (m) |
| 2024-03-31 | (m) | $-8.42M | (m) |
| 2023-12-31 | (m) | $-6.28M | (m) |
| 2023-09-30 | (m) | $-2.43M | (m) |
| 2023-06-30 | (m) | $-1.78M | (m) |
| 2023-03-31 | (m) | $-3.99M | (m) |
| 2022-12-31 | (m) | $-5.57M | (m) |
| 2022-09-30 | (m) | $-6.98M | (m) |
| 2022-06-30 | (m) | $-7.62M | (m) |
| 2022-03-31 | (m) | $-5.06M | (m) |
| 2021-12-31 | (m) | $-3.51M | (m) |
| 2021-09-30 | (m) | $-543.67K | (m) |
| 2021-06-30 | (m) | $29.88K | (m) |
| 2021-03-31 | (m) | $-2.12M | (m) |
| 2020-12-31 | (m) | $-3.34M | (m) |
| 2020-09-30 | (m) | $-3.42M | (m) |
| 2020-06-30 | (m) | $-4.89M | (m) |
| 2020-03-31 | (m) | $-4.52M | (m) |
| 2019-12-31 | (m) | $-3.54M | (m) |
| 2019-09-30 | (m) | $-4.80M | (m) |
| 2019-06-30 | (m) | $-4.49M | (m) |
| 2019-03-31 | (m) | $-4.66M | (m) |
| 2018-12-31 | (m) | $-6.96M | (m) |
| 2018-09-30 | (m) | $-5.54M | (m) |
| 2018-06-30 | (m) | $-4.64M | (m) |
| 2018-03-31 | (m) | $-9.08M | (m) |
| 2017-12-31 | (m) | $-7.98M | (m) |
| 2017-09-30 | (m) | $-7.93M | (m) |
| 2017-06-30 | (m) | $-7.08M | (m) |
| 2017-03-31 | (m) | $-1.97M | (m) |
| 2016-12-31 | (m) | $-944.68K | (m) |
| 2016-09-30 | (m) | $-43.93K | (m) |
| 2016-06-30 | (m) | $-22.08K | (m) |
| 2016-03-31 | (m) | $431.96K | (m) |
| 2015-12-31 | (m) | $731.35K | (m) |
| 2015-09-30 | (m) | $1.25M | (m) |
| 2015-06-30 | (m) | $1.87M | (m) |
| 2015-03-31 | (m) | $2.18M | (m) |
| 2014-12-31 | (m) | $2.42M | (m) |
| 2014-09-30 | (m) | $254.45K | (m) |
| 2014-06-30 | (m) | $-1.31M | (m) |
| 2014-03-31 | (m) | $-2.67M | (m) |
| 2013-12-31 | (m) | $-2.10M | (m) |
| 2013-09-30 | (m) | $1.20M | (m) |
| 2013-06-30 | (m) | $3.89M | (m) |
| 2013-03-31 | (m) | $6.27M | (m) |
| 2012-12-31 | (m) | $5.84M | (m) |
| 2012-09-30 | (m) | $4.95M | (m) |
| 2012-06-30 | (m) | $4.93M | (m) |
| 2012-03-31 | (m) | $5.36M | (m) |
| 2011-12-31 | (m) | $5.66M | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $2.46M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $3.09M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |